Two teams examined the impact of the InsuPad device, which heats the skin after insulin injections, and the InsuPatch device, used with insulin infusions from pump devices.
Findings presented at the 2012 meeting of the European Association for the Study of Diabetes (EASD) in Berlin this week showed beneficial effects from the use of both devices.
Use of the InsuPad in 10 people with type 2 diabetes led to smaller rises in blood glucoses levels after meals, according to researchers from Insuline Medical in Petach Tikva, Israel.
In 56 people with type 1 diabetes, the InsuPatch device was found to enhance insulin absorption and reduce the duration of glucose-lowering action, according to a team from the Wolfson Medical Centre in Holon, Israel.
